716 related articles for article (PubMed ID: 18672129)
1. Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation.
Chambers MS; Tomsett KL; Artopoulou II; Garden AS; El-Naggar AK; Martin JW; Keene HJ
J Prosthet Dent; 2008 Aug; 100(2):142-6. PubMed ID: 18672129
[TBL] [Abstract][Full Text] [Related]
2. Salivary status in patients treated for head and neck cancer.
Dawes C; Odlum O
J Can Dent Assoc; 2004 Jun; 70(6):397-400. PubMed ID: 15175120
[TBL] [Abstract][Full Text] [Related]
3. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
4. Dramatic and prolonged decrease of whole salivary secretion in nasopharyngeal carcinoma patients treated with radiotherapy.
Jen YM; Lin YC; Wang YB; Wu DM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Mar; 101(3):322-7. PubMed ID: 16504865
[TBL] [Abstract][Full Text] [Related]
5. The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours.
Cankar K; Finderle Z; Jan J
Caries Res; 2011; 45(2):136-41. PubMed ID: 21447949
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
7. The effect of acupuncture on salivary flow rates in patients with radiation-induced xerostomia.
Braga FP; Sugaya NN; Hirota SK; Weinfeld I; Magalhães MH; Migliari DA
Minerva Stomatol; 2008; 57(7-8):343-8. PubMed ID: 18784633
[TBL] [Abstract][Full Text] [Related]
8. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
[TBL] [Abstract][Full Text] [Related]
9. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
[TBL] [Abstract][Full Text] [Related]
10. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
12. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
[TBL] [Abstract][Full Text] [Related]
13. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.
Meirovitz A; Murdoch-Kinch CA; Schipper M; Pan C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):445-53. PubMed ID: 16839705
[TBL] [Abstract][Full Text] [Related]
14. The effects of electrostimulation on parotid saliva flow: a pilot study.
Hargitai IA; Sherman RG; Strother JM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):316-20. PubMed ID: 15716838
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.
Saarilahti K; Kouri M; Collan J; Hämäläinen T; Atula T; Joensuu H; Tenhunen M
Radiother Oncol; 2005 Mar; 74(3):251-8. PubMed ID: 15763305
[TBL] [Abstract][Full Text] [Related]
16. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology.
Cho MA; Ko JY; Kim YK; Kho HS
J Oral Rehabil; 2010 Mar; 37(3):185-93. PubMed ID: 20002531
[TBL] [Abstract][Full Text] [Related]
17. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
Khurshudian AV
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
[TBL] [Abstract][Full Text] [Related]
18. Whole salivary flow rates following submandibular gland resection.
Jacob RF; Weber RS; King GE
Head Neck; 1996; 18(3):242-7. PubMed ID: 8860765
[TBL] [Abstract][Full Text] [Related]
19. Quantifying radioxerostomia: salivary flow rate, examiner's score, and quality of life questionnaire.
Al-Nawas B; Al-Nawas K; Kunkel M; Grötz KA
Strahlenther Onkol; 2006 Jun; 182(6):336-41. PubMed ID: 16703289
[TBL] [Abstract][Full Text] [Related]
20. The role of submandibular salivary gland transfer in preventing xerostomia in the chemoradiotherapy patient.
Al-Qahtani K; Hier MP; Sultanum K; Black MJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):753-6. PubMed ID: 16731395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]